🎁 Black Friday: up to 50% off of annual plans
Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.00
-1.35 (-4.60%)
Nov 20, 2026, 1:30 PM CST

Nang Kuang Pharmaceutical Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,0882,1622,2002,1501,9401,780
Revenue Growth
-6.10%-1.71%2.31%10.81%9.01%1.44%
Cost of Revenue
1,3651,3931,4521,3951,2461,186
Gross Profit
723.04768.86747.79755.56694.9594.47
Selling, General & Admin
312.38302.62270.88252.78227.29204.05
Research & Development
157.28170.58169.36164.11143.81133.97
Operating Expenses
469.68473.19437.57495.72373.24339.99
Operating Income
253.37295.67310.22259.84321.67254.48
Interest Expense
-9.16-8.59-5.53-7.18-4.84-3.53
Interest & Investment Income
3.143.12310.642.693.46
Currency Exchange Gain (Loss)
4.534.538.64.18.79-11.98
Other Non Operating Income (Expenses)
-13.5111.189.829.449.2510.04
EBT Excluding Unusual Items
238.36305.9326.11276.85337.56252.47
Gain (Loss) on Sale of Investments
-14.3-14.3-23.07-1.8573.110.14
Gain (Loss) on Sale of Assets
-0.09-0.090.176.1-0.05-0.15
Legal Settlements
-0.37-0.37--67.43--22.96
Other Unusual Items
---0-5.26
Pretax Income
223.6291.14303.2213.68410.63234.76
Income Tax Expense
37.4247.259.815.2758.6338.65
Earnings From Continuing Operations
186.18243.95243.41198.41352196.11
Minority Interest in Earnings
2.130.47----
Net Income
188.31244.41243.41198.41352196.11
Net Income to Common
188.31244.41243.41198.41352196.11
Net Income Growth
-26.75%0.41%22.68%-43.63%79.49%6.93%
Shares Outstanding (Basic)
101101101101101101
Shares Outstanding (Diluted)
102101101101101101
Shares Change
0.26%0.02%0.10%-0.08%-0.01%0.03%
EPS (Basic)
1.862.422.411.963.491.94
EPS (Diluted)
1.852.412.401.963.481.94
EPS Growth
-27.13%0.42%22.45%-43.68%79.38%7.18%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
5.85186.25-58.1745.1275.35400.58
Free Cash Flow Per Share
0.061.84-0.570.452.723.96
Dividend Per Share
--1.6002.0002.3001.800
Dividend Growth
---20.00%-13.04%27.78%12.50%
Gross Margin
34.62%35.56%33.99%35.14%35.81%33.40%
Operating Margin
12.13%13.67%14.10%12.08%16.58%14.30%
Profit Margin
9.02%11.30%11.06%9.23%18.14%11.02%
Free Cash Flow Margin
0.28%8.61%-2.64%2.10%14.19%22.50%
EBITDA
434.07478.06492.34440.76496.66433.33
EBITDA Margin
20.78%22.11%22.38%20.50%25.59%24.34%
D&A For EBITDA
180.7182.39182.12180.92174.99178.85
EBIT
253.37295.67310.22259.84321.67254.48
EBIT Margin
12.13%13.67%14.10%12.08%16.58%14.30%
Effective Tax Rate
16.74%16.21%19.72%7.15%14.28%16.46%